In a market note on Wednesday, Zacks Research gave Hims & Hers Health, Inc. (NYSE:HIMS) a “strong buy” recommendation on ...

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

Cambridge Terahertz’s package screening technology could help reduce fraudulent returns, a problem that’s plagued Amazon.

The Consolidated Personal Property Shipping Office (CPPSO) under Base Support Operations Transportation (BASOPS Trans), 405th ...

HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.

U.S. equities opened strongly, with the S&P 500 and Nasdaq reaching all‑time highs as investors rallied on improving trade ...